Olfactory function and dysfunction;Riechen: Normale funktion und störungen

Aktuelle Neurologie

Volumn 32, Issue 1, 2005, Pages 15-27

  Muller A ^a   Landis, B N ^b   Zahnert, T ^a   Reichmann, H ^a   Hummel, Thomas ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; CAROVERINE; CORTICOSTEROID; ESTROGEN; GLUTAMIC ACID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; SUBSTANCE P;

ACUPUNCTURE; ALZHEIMER DISEASE; ANTIBIOTIC THERAPY; BRAIN TUMOR; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORTICOSTEROID THERAPY; DEGENERATIVE DISEASE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; ENDOCRINE DISEASE; EPILEPSY; FUNCTIONAL ASSESSMENT; HUMAN; HUNTINGTON CHOREA; NEUROPROTECTION; NONHUMAN; OLFACTORY SYSTEM; PARKINSON DISEASE; POLYPECTOMY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; RISK FACTOR; SMELLING; SMELLING DISORDER; SURGICAL TECHNIQUE; SYMPTOM; TECHNIQUE;

EID: 14344260064     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834578     Document Type: Review

References (220)

1. rd ed. New York, NY: Elsevier Science Publishing Co, 1991: 512-529
2. Small DM, Gregory MD, Mak YE et al. Dissociation of neural representation of intensity and affective valuation in human gustation. Neuron 2003; 39: 701-711
3. Anderson AK, Christoff K, Stappen I et al. Dissociated neural representations of intensity and valence in human olfaction. Nat Neurosci 2003; 6: 196-202
4. Herz RS. Scents of time. The Sciences 2000; July/August: 34-39
5. Skramlik E von. Handbuch der Physiologie der niederen Sinne. Leipzig: Georg Thieme, 1926
6. Elsberg CA, Levy I, Brewer ED. The sense of smell VI. The trigeminal effects of odorous substances. Bull Neurol Inst NY 1935; 4: 270-285
7. Doty RL, Brugger WPE, Jurs PC et al. Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 1978; 20: 175-185
8. Kobal G, Toller S Van, Hummel T. Is there directional smelling? Experientia 1989; 45: 130-132
9. Hummel T. Assessment of intranasal trigeminal function. Int J Psychophysiol 2000; 36: 147-155
10. Cain WS. Contribution of the trigeminal nerve to perceived odor magnitude. Ann N Y Acad Sci 1974; 237: 28-34
11. Cain WS, Murphy C. Interaction between chemoreceptive modalities of odour and irritation. Nature 1980; 284: 255-257
12. Hummel T, Livermore A. Intranasal chemosensory function of the trigeminal nerve and aspects of its relation to olfaction. Int Arch Occ Env Health 2002; 75: 305-313
13. Hummel T, Barz S, Lotsch J et al. Loss of olfactory function leads to a decrease of trigeminal sensitivity. Chem Senses 1996; 21: 75-79
14. Gudziol H, Schubert M, Hummel T. Decreased trigeminal sensitivity in anosmia. ORL J Otorhinolaryngol Relat Spec 2001; 63: 72-75
15. Krause F. Die Physiologie des Trigeminus nach Untersuchungen an Menschen, bei denen das Ganglion Gasseri entfernt worden ist. Münch Med Woschr 1895; 27: 628-631
16. Buck L, Axel R. A novel multigene family may encode odorant receptors: a molecular basis for odor recognition. Cell 1991; 65: 175-187
17. Gilad Y, Man O, Paabo S et al. Human specific loss of olfactory receptor genes. Proc Natl Acad Sci U S A 2003; 28: 28
18. Gilad Y, Wiebe V, Przeworski M et al. Loss of olfactory receptor genes coincides with the acquisition of full trichromatic vision in primates. PLoS Biol 2004; 2: E5. Epub 2004 Jan 20
19. Strotmann J, Wanner I, Helfrich T et al. Olfactory neurones expressing distinct odorant receptor subtypes are spatially segregated in the nasal neuroepithelium. Cell Tissue Res 1994; 276: 429-438
20. Vassar R, Ngai J, Axel R. Spatial segregation of odorant receptor expression in the mammalian olfactory epithelium. Cell 1993; 74: 309-318
21. Vassar R, Chao SK, Sitcheran R et al. Topographic organization of sensory projections to the olfactory bulb. Cell 1994; 79: 981-991
22. Axel R. The molecular logic of smell. Sci Am 1995; 273: 154-159
23. Zhao H, Ivic L, Otaki JM et al. Functional expression of a mammalian odorant receptor. Science 1998; 279: 237-242
24. Araneda RC, Kini AD, Firestein S. The molecular receptive range of an odorant receptor. Nat Neurosci 2000; 3: 1248-1255
25. Uchida N, Takahashi YK, Tanifuji M et al. Odor maps in the mammalian olfactory bulb: domain organization and odorant structural features. Nat Neurosci 2000; 3: 1035-1043
26. Malnic B, Hirono J, Sato T et al. Combinatorial receptor codes for odors. Cell 1999; 96: 713-723
27. Landis BN, Hummel T, Hugentobler M et al. Ratings of overall olfactory function. Chem Senses 2003; 28: 691-694
28. Huttenbrink KB. Riech- und Schmeckstörungen: Bewährtes und Neues zu Diagnostik und Therapie. Laryngorhinootologie 1997; 76: 506-514
29. Seiden AM. The intial assessment of patients with taste and smell disorders. In: Seiden AM (ed): Taste and Smell Disorders. New York: Thieme, 1997: 4-19
30. Hummel T, Konnerth CG, Rosenheim K et al. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001; 110: 976-981
31. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984; 32: 489-502
32. Cain WS, Gent JF, Goodspeed RB et al. Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center (CCCRC). Laryngoscope 1988; 98: 83-88
33. Kobal G, Hummel T, Sekinger B et al. "Sniffin' sticks": screening of olfactory performance. Rhinology 1996; 34: 222-226
34. Hummel T, Sekinger B, Wolf S et al. "Sniffin' Sticks": Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; 22: 39-52
35. Kobal G, Klimek L, Wolfensberger M et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 2000; 257: 205-211
36. Kondo H, Matsuda T, Hashiba M et al. A study of the relationship between the T&T olfactometer and the University of Pennsylvania Smell Identification Test in a Japanese population. Am J Rhinol 1998; 12: 353-358
37. Briner HR, Simmen D. Smell diskettes as screening test of olfaction. Rhinology 1999; 37: 145-148
38. Ho WK, Kwong DL, Wei WI et al. Change in olfaction after radiotherapy for nasopharyngeal cancer - a prospective study. Am J Otolaryngol 2002; 23: 209-214
39. Ehrenstein WH, Ehrenstein A. Psychophysical methods. In: Windhorst U, Johansson H (eds): Modern Techniques in Neuroscience Research. Berlin: Springer, 1999: 1211-1241
40. Hawkes CH, Shephard BC. Selective anosmia in Parkinson's disease? Lancet 1993; 341: 435-436
41. Koss E, Weiffenbach JM, Haxby JV et al. Olfactory detection and recognition in Alzheimer's disease. Lancet 1987; 1: 622
42. Koss E, Weiffenbach JM, Haxby JV et al. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988; 38: 1228-1232
43. Frasnelli JA, Temmel AF, Quint C et al. Olfactory function in chronic renal failure. Am J Rhinol 2002; 16: 275-279
44. Hornung DE, Kurtz DB, Bradshaw CB et al. The olfactory loss that accompanies an HIV infection. Physiol Behav 1998; 15: 549-556
45. Jones-Gotman M, Zatorre RJ. Olfactory identification deficits in patients with focal cerebral excision. Neuropsychologia 1988; 26: 387-400
46. Mesholam RI, Moberg PJ, Mahr RN et al. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; 55: 84-90
47. Daum RF, Sekinger B, Kobal G et al. Riechprüfung mit "Sniffin' Sticks" zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt 2000; 71: 643-650
48. Klimek L, Hummel T, Moll B et al. Lateralized and bilateral olfactory function in patients with chronic sinusitis compared with healthy control subjects. Laryngoscope 1998; 108: 111-114
49. Ottoson D. Analysis of the electrical activity of the olfactory epithelium. Acta Physiol Scand 1956; 35: 1-83
50. Hummel T, Knecht M, Kobal G. Peripherally obtained electrophysiological responses to olfactory stimulation in man: electro-olfactograms exhibit a smaller degree of desensitization compared with subjective intensity estimates. Brain Res 1996; 717: 160-164
51. Leopold DA, Hummel T, Schwob JE et al. Anterior distribution of human olfactory epithelium. Laryngoscope 2000; 110: 417-421
52. Wang L, Chen L, Jacob T. Evidence for peripheral plasticity in human odour response. J Physiol 2004; 554: 236-244
53. Spehr M, Schwane K, Barbour J et al. The HOR17-4 signalling system - one receptor, dual capacity. Chem Sens, 2005 (in press)
54. Picton TW, Hillyard SA. Endogenous event-related potentials. In: Picton TW (ed): EEG-Handbook, Revised Series, Vol. 3. Amsterdam: Elsevier, 1988: 361-426
55. Finkenzeller P. Gemittelte EEG-Potentiale bei olfaktorischer Reizung. Pflügers Arch 1965; 292: 76-85
56. Kobal G, Plattig KH. Methodische Anmerkungen zur Gewinnung olfaktorischer EEG-Antworten des wachen Menschen (objektive Olfaktometrie). Z EEG-EMG 1978; 9: 135-145
57. Kobal G. Elektrophysiologische Untersuchungen des menschlichen Geruchssinns. Stuttgart: Thieme Verlag, 1981
58. Kobal G, Hummel T. Olfactory evoked potentials in humans. In: Getchell TV, Doty RL, Bartoshuk LM et al. (eds): Smell and Taste in Health and Disease. New York: Raven Press, 1991: 255-275
59. Pause BM, Sojka B, Krauel K et al. The nature of the late positive complex within the olfactory event-related potential. Psychophysiology 1996; 33: 168-172
60. Krauel K, Pause BM, Sojka B et al. Attentional modulation of central odor processing. Chem Senses 1998; 23: 423-432
61. Donchin E, Karis D, Bashore TR et al. Cognitive psychophysiology and human information processing. In: Coles MGH, Donchin E, Porges SW (eds): Psychophysiology: Systems, Processes and Applications. New York: Guilford Press, 1986
62. Hummel T, Klimek L, Welge-Lussen A et al. Chemosensorisch evozierte Potentiale zur klinischen Diagnostik von Riechstörungen. HNO 2000; 48: 481-485
63. Kobal G, Hummel T, Toller S Van. Differences in chemosensory evoked potentials to olfactory and somatosensory chemical stimuli presented to left and right nostrils. Chemical Senses 1992; 17: 233-244
64. Pause B, Sojka B, Ferstl R. The latency but not the amplitude of the olfactory event-related potential (OERP) varies with the odor concentration. Chemical Senses 1996; 21: 485
65. Murphy C, Wetter S, Morgan CD et al. Age effects on central nervous system activity reflected in the olfactory event-related potential. Evidence for decline in middle age. Ann N Y Acad Sci 1998; 855: 598-607
66. Lorig TS, Matia DC, Pezka JJ et al. The effects of active and passive stimulation on chemosensory event-related potentials. Int J Psychophysiol 1996; 23: 199-205
67. Williamson SJ, Kaufman L. Analysis of neuromagnetic signals. In: Gevins AS, Rèmond AA (eds): Handbook of Electroencephalography and Clinical Neurophysiology, Volume 1: Methods of Brain Electrical and Magnetical Signals. Amsterdam: Elsevier, 1987: 405-448
68. 2-stimulation of nasal mucosa: a magnetencephalographic study in man. Electroenceph Clin Neurophysiol 1986; 64: 347-349
69. 2 stimulation of the human nasal mucosa. Pain 1997; 72: 145-151
70. Kettenmann B, Hummel C, Stefan H et al. Magnetoencephalographical recordings: separation of cortical responses to different chemical stimulation in man. Funct Neurosci (EEG Suppl) 1996; 46: 287-290
71. Kettenmann B, Hummel C, Stefan H et al. Multiple olfactory activity in the human neocortex identified by magnetic source imaging. Chem Senses 1997; 22: 493-502
72. Ayabe-Kanamura S, Endo H, Kobayakawa T et al. Measurement of olfactory evoked magnetic fields by a 64-channel whole-head SQUID system. Chemical Senses 1997; 22: 214-215
73. Kobal G, Hummel C. Cerebral chemosensory evoked potentials elicited by chemical stimulation of the human olfactory and respiratory nasal mucosa. Electroenceph Clin Neurophysiol 1988; 71: 241-250
74. Kobal G, Hummel T. Olfactory and intranasal trigeminal event-related potentials in anosmic patients. Laryngoscope 1998; 108: 1033-1035
75. Savic I. Imaging of brain activation by odorants in humans. Curr Opin Neurobiol 2002; 12: 455-461
76. Zald DH, Pardo JV. Functional neuroimaging of the olfactory system in humans. Int J Psychophysiol 2000; 36: 165-181
77. Kettenmann B, Hummel T, Kobal G. Functional imaging of olfactory activation in the human brain. In: Simon SA, Nicolelis MAL (eds): Methods and Frontiers in Chemosensory Research. Bacon Raton, Florida, USA: CRC press, 2001: 477-506
78. Small DM, Jones-Gotman M, Zatorre RJ et al. Flavor processing: more than the sum of its parts. Neuroreport 1997; 8: 3913-3917
79. Kareken DA, Sabri M, Radnovich AJ et al. Olfactory system activation from sniffing: effects in piriform and orbitofrontal cortex. Neuroimage 2004; 22: 456-465
80. Savic I, Berglund H. Passive perception of odors and semantic circuits. Hum Brain Mapp 2004; 21: 271-278
81. Sobel N, Prabhakaran V, Zhao Z et al. Time course of odorant-induced activation in the human primary olfactory cortex. J Neurophysiol 2000; 83: 537-551
82. Poellinger A, Thomas R, Lio P et al. Activation and habituation in olfaction - an fMRI study. Neuroimage 2001; 13: 547-560
83. Sobel N, Prabhakaran V, Hartley CA et al. Odorant-induced and sniff-induced activation in the cerebellum of the human. J Neurosci 1998; 18: 8990-9001
84. Yousem DM, Maldjian JA, Hummel T et al. The effect of age on odor-stimulated functional MR imaging. Am J Neuroradiol 1999; 20: 600-608
85. Amoore JE. Specific anosmia and the concept of primary odors. Chem Sens Flav 1977; 2: 267-281
86. Hummel T, Maroldt H, Frasnelli J et al. Häufigkeit und mögliche prognostische Bedeutung qualitativer Riechstörungen. HNO-Informationen 2004; 29: 122
87. Kaufman MD, Lassiter KR, Shenoy BV. Paroxysmal unilateral dysosmia: a cured patient. Ann Neurol 1988; 24: 450-451
88. Miwa T, Furukawa M, Tsukatani T et al. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg 2001; 127: 497-503
89. Temmel AF, Quint C, Schickinger-Fischer B et al. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002; 128: 635-641
90. Santos DV, Reiter ER, DiNardo LJ et al. Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg 2004; 130: 317-319
91. Hummel T, Nordin S. Olfactory disorders and their consequences for quality of life - A review. Acta Oto-Laryngol, 2005 (in press)
92. Wysocki CJ, Gilbert AN. National Geographic Smell Survey: effects of age are heterogenous. Ann NY Acad Sci 1989; 561: 12-28
93. Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci 1998; 855: 716-722
94. Murphy C, Schubert CR, Cruickshanks KJ et al. Prevalence of olfactory impairment in older adults. JAMA 2002; 288: 2307-2312
95. Brämerson A, Johansson L, Ek L et al. Prevalence of olfactory dysfunction: The Skövde population-based study. Laryngoscope 2004; 114: 733-737
96. Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope 2004; 114: 1764-1769
97. Quint C, Temmel AF, Schickinger B et al. Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna. Wien Klin Wochenschr 2001; 113: 52-57
98. Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope 2001; 111: 9-14
99. Deems DA, Doty RL, Settle RG et al. Smell and taste disorders: a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otorhinolaryngol Head Neck Surg 1991; 117: 519-528
100. Damm M, Temmel A, Welge-Lüssen A et al. Epidemiologie und Therapie von Riechstörungen in Deutschland, Österreich und der Schweiz. HNO 2004; 52: 112-120
101. Hotchkiss WT. Influence of prednisone on nasal polyposis with anosmia. Arch Otolaryngol 1956; 64: 478-479
102. Seiden AM. Olfactory loss secondary to nasal and sinus pathology. In: Seiden AM (ed): Taste and Smell Disorders. New York: Thieme, 1997: 52-71
103. Landis BN, Giger R, Ricchetti A et al. Retronasal olfactory function in nasal polyposis. Laryngoscope 2003; 113: 1993-1997
104. Apter AJ, Mott AE, Frank ME et al. Allergic rhinitis and olfactory loss. Ann Allergy Asthma Immunol 1995; 75: 311-316
105. Stuck BA, Blum A, Hagner AE et al. Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis. Allergy 2003; 58: 1195
106. Lanza DC, Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 1997; 117: 1-7
107. Jafek BW, Hartman D, Eller PM et al. Postviral olfactory dysfunction. Am J Rhinol 1990; 4: 91-100
108. Sugiura M, Aiba T, Mori J et al. An epidemiological study of postviral olfactory disorder. Acta Otolaryngol Suppl (Stockh) 1998; 538: 191-196
109. Faulcon P, Portier F, Biacabe B et al. Anosmie secondaire à une rhinite aiguë: sémiologie et évolution à propos d'une série de 118 patients. Ann Otolaryngol Chir Cervicofac 1999; 116: 351-357
110. Duncan HJ, Seiden AM. Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch Otolaryngol Head Neck Surg 1995; 121: 1183-1187
111. Quint C, Temmel AFP, Hummel T et al. The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof of concept study. Acta Otolaryngol 2002; 122: 877-881
112. Hummel T, Heilmann S, Hüttenbrink KB. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope 2002; 112: 2076-2080
113. Dhong HJ, Chung SK, Doty RL. Estrogen protects against 3-methylindole-induced olfactory loss. Brain Res 1999; 824: 312-315
114. Hughes LF, McAsey ME, Donathan CL et al. Effects of hormone replacement therapy on olfactory sensitivity: cross-sectional and longitudinal studies. Climacteric 2002; 5: 140-150
115. Portier F, Faulcon P, Lamblin B et al. Sémiologie, étiologie et évolution des parosmies: à propos de 84 cas. Ann Otolaryngol Chir Cervicofac 2000; 117: 12-18
116. Frasnelli J, Landis BN, Heilmann S et al. Clinical presentation of qualitative olfactory dysfunction. Eur Arch Otorhinolaryngol 2003; 11: 11-13
117. Frasnelli J, Hummel T. Olfactory dysfunction and daily life. Eur Arch Otolaryngol, 2004 [Epub ahead of print]
118. Legg JW. A case of anosmia following a blow. Lancet 1873; 2: 659-660
119. Yousem DM, Geckle RJ, Bilker WB et al. Posttraumatic smell loss: relationship of psychophysical tests and volumes of the olfactory bulbs and tracts and the temporal lobes. Acad Radiol 1999; 6: 264-272
120. Zusho H. Posttraumatic anosmia. Arch Otolaryngol 1982; 108: 90-92
121. Sumner D. Post-traumatic anosmia. Brain 1964; 87: 107-120
122. Delank KW, Fechner G. Zur Pathophysiologie der posttraumatischen Riechstörungen. Laryngol Rhinol Otol 1996; 75: 154-159
123. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J Chron Dis 1975; 28: 493-497
124. Ward CD, Hess WA, Calne DB. Olfactory impairment in Parkinson's disease. Neurology 1983; 33: 943-946
125. Doty RL, Deems D, Steller S. Olfactory dysfunction in Parkinson's disease: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988; 38: 1237-1244
126. Sobel N, Thomason ME, Stappen I et al. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad Sci U S A 2001; 98: 4154-4159
127. Barz S, Hummel T, Pauli E et al. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 1997; 49: 1424-1431
128. Hawkes CH, Shephard BC. Olfactory evoked responses and identification tests in neurological disease. Ann N Y Acad Sci 1998; 855: 608-615
129. Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995; 10: 283-287
130. Hawkes CH, Shephard BC, Daniel SE. Is Parkinson's disease a primary olfactory disorder? Qjm 1999; 92: 473-480
131. Hawkes C. Olfactory testing in parkinsonism. Lancet Neurol 2004; 3: 393-394
132. Berendse HW, Booij J, Francot CM et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 2001; 50: 34-41
133. Sommer U, Hummel T, Cormann K et al. Detection of presymptomatic Parkinson's disease: combination of olfactory tests, transcranial sonography, and 123 I-FP-CI-SPECT. Mov Disord 2004; 19: 1196-1202
134. Hamilton JM, Murphy C, Paulsen JS. Odor detection, learning, and memory in Huntington's disease. J Int Neuropsychol Soc 1999; 5: 609-615
135. Hawkes CH. Olfaction in neurodegenerative disease. Mov Disord 2003; 18: 364-372
136. Muller A, Reichmann H, Livermore A et al. Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm 2002; 109: 805-811
137. Jorgensen MB, Buch NH. Studies on the sense of smell and taste in diabetics. Arch Otolaryngol 1961; 53: 539-545
138. Weinstock RS, Wright HN, Smith DU. Olfactory dysfunction in diabetes mellitus. Physiol Behav 1993; 53: 17-21
139. Doty RL. Gender and endocrine-related influences upon olfactory sensitivity. In: Meiselman H, Rivlin RS (eds): Clinical Measurement of Taste and Smell. New York: MacMillan, 1986: 377-413
140. Henkin RI, Bartter FC. Studies on olfactory thresholds in normal man and in patients with adrenal cortical insufficiency: the role of adrenal cortical steroids and of serum sodium concentration. J Clin Invest 1966; 45: 1631-1639
141. Schiffman SS. Taste and smell in disease (second of two parts). N Engl J Med 1983; 308: 1337-1343
142. Schiffman SS. Taste and smell in disease (first of two parts). N Engl J Med 1983; 308: 1275-1279
143. Campanella G, Filla A, Michele G De. Smell and taste acuity in epileptic syndromes. Eur Neurol 1978; 17: 136-141
144. Eskenazi B, Cain WS, Novelly RA et al. Odor perception in temporal lobe epilepsy patients with and without temporal lobectomy. Neuropsychologia 1986; 24: 553-562
145. Jones-Gotman M, Zatorre RJ. Contribution of the right temporal lobe to odor memory. Epilepsia 1988; 29: 661
146. Jones-Gotman M, Zatorre RJ, Cendes F et al. Contribution of medial versus lateral temporal-lobe structures to human odour identification. Brain 1997; 120: 1845-1856
147. Kohler CG, Moberg PJ, Gur RE et al. Olfactory dysfunction in schizophrenia and temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 2001; 4: 83-88
148. Hummel T, Pauli E, Schuler P et al. Chemosensory event-related potentials in patients with temporal lobe epilepsy. Epilepsia 1995; 36: 79-85
149. Adelman BT. Altered taste and smell after anesthesia: cause and effect? Anesthesiology 1995; 83: 647-649
150. Kimmelman CP. The risk to olfaction from nasal surgery. Laryngoscope 1994; 104: 981-988
151. Damm M, Eckel HE, Jungehulsing M et al. Olfactory changes at threshold and suprathreshold levels following septoplasty with partial inferior turbinectomy. Ann Otol Rhinol Laryngol 2003; 112: 91-97
152. Briner HR, Simmen D, Jones N. Impaired sense of smell in patients with nasal surgery. Clin Otolaryngol 2003; 28: 417-419
153. Hastings L, Miller ML. Olfactory loss to toxic exposure. In: Seiden AM (ed): Taste and Smell Disorders. New York: Thieme, 1997: 88-106
154. Doty RL, Philip S, Reddy K et al. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertens 2003; 21: 1805-1813
155. Kharoubi S. Anosmie toxi-médicamenteuse à la nifédipine. Presse Med 2003; 32: 1269-1272
156. Levenson JL, Kennedy K. Dysosmia, dysgeusia, and nifedipine. Ann Intern Med 1985; 102: 135-136
157. Welge-Luessen A, Wolfensberger M. Reversible anosmia after amikacin therapy. Arch Otolaryngol Head Neck Surg 2003; 129: 1331-1333
158. Jafek BW, Gordon AS, Moran DT et al. Congenital anosmia. Ear Nose Throat J 1990; 69: 331-337
159. Yousem DM, Geckle RJ, Bilker W et al. MR evaluation of patients with congenital hyposmia or anosmia. Am J Radiol 1996; 166: 439-443
160. Abolmaali ND, Hietschold V, Vogl TJ et al. MR evaluation in patients with isolated anosmia since birth or early childhood. AJNR Am J Neuroradiol 2002; 23: 157-164
161. Kallmann FJ, Schoenfeld WA, Barrera SE. The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944; 48: 203-236
162. Smith DV, Seiden AM. Olfactory dysfunction. In: Laing DG, Doty RL, Breipohl W (eds): The Human Sense of Smell. Berlin: Springer, 1991: 283-305
163. Welge-Luessen A, Temmel A, Quint C et al. Olfactory function in patients with olfactory groove meningioma. J Neurol Neurosurg Psych 2001; 70: 218-221
164. Henkin RI, Smith FR. Hyposmia in acute viral hepatitis. Lancet 1971; 1: 823-826
165. Kleinschmidt EG, Kramp B, Schwager A. Functional study on the sense of smell in patients with chronic liver disease. Z Gesamte Inn Med 1976; 31: 853-856
166. Reaich D. Odour perception in chronic renal disease. Lancet 1997; 350: 1191
167. Doty RL, Yousem DM, Pham LT et al. Olfactory dysfunction in patients with head trauma. Arch Neurol 1997; 54: 1131-1140
168. Hendriks APJ. Olfactory dysfunction. Rhinology 1988; 26: 229-251
169. Bonfils P, Corre FL, Biacabe B. Semiologie et etiologie des anosmies: a propos de 306 patients. Ann Otolaryngol Chir Cervicofac 1999; 116: 198-206
170. Murphy C, Doty RL, Duncan HJ. Clinical disorders of olfaction. In: Doty RL (ed): Handbook of Olfaction and Gustation. New York: Marcel Dekker, 2003: 461-478
171. Beidler LM, Smallman RL. Renewal of cells within taste buds. J Cell Bio 1965; 27: 263-272
172. Gradziadei PPC, Monti-Graziadei GA. Continuous nerve cell renewal in the olfactory system. In: Jacobson M (ed): Handbook of Sensory Physiology, Vol. IX. New York: Springer, 1978: 55
173. Wolfensberger M, Hummel T. Anti-inflammatory and surgical therapy of olfactory disorders related to sino-nasal disease. Chem Senses 2002; 27: 617-622
174. Golding-Wood DG, Holmstrom M, Darby Y et al. The treatment of hyposmia with intranasal steroids. J Laryngol Otol 1996; 110: 132-135
175. Tos M, Svendstrup F, Arndal H et al. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinol 1998; 12: 183-189
176. Mott AE, Cain WS, Lafreniere D et al. Topical corticosteroid treatment of anosmia associated with nasal and sinus disease. Arch. Otolaryngol. Head Neck Surg 1997; 123: 367-372
177. Stevens MH. Steroid-dependent anosmia. Laryngoscope 2001; 111: 200-203
178. Mott AE, Leopold DA. Disorders in taste and smell. Med Clin North Am 1991; 75: 1321-1353
179. Klimek L, Eggers G. Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation. J Allergy Clin Immunol 1997; 100: 159-164
180. Jafek BW, Moran DT, Eller PM et al. Steroid-dependent anosmia. Arch Otolaryngol Head Neck Surg 1987; 113: 547-549
181. Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 2000; 79: 18-20, 24-25
182. Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otorhinolaryngol 2000; 257: 537-541
183. Rundles W. Prognosis in the neurologic manifestations of pernicious anemia. Blood 1946; 1: 209-219
184. Stevenson DD, Hankammer MA, Mathison DA et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996; 98: 751-758
185. Moran DT, Jafek BW, Eller PM et al. Ultrastructural histopathology of human olfactory dysfunction. Microsc Res Tech 1992; 23: 103-110
186. Yamagishi M, Fujiwara M, Nakamura H. Olfactory mucosal findings and clinical course in patients with olfactory disorders following upper respiratory viral infection. Rhinology 1994; 32: 113-118
187. Henkin RI, Schecter PJ, Friedewald WT et al. A double-blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976; 272: 285-299
188. Yee KK, Rawson NE. Retinoic acid enhances the rate of olfactory recovery after olfactory nerve transection. Brain Res Dev Brain Res 2000; 124: 129-132
189. Reljanovic M, Reichel G, Rett K et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 1999; 31: 171-179
190. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-895
191. Hounsom L, Horrobin DF, Tritschler H et al. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy. Diabetologia 1998; 41: 839-843
192. Hounsom L, Corder R, Patel J et al. Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy. Diabetologia 2001; 44: 424-428
193. Garrett NE, Malcangio M, Dewhurst M et al. Alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett 1997; 222: 191-194
194. Coppey LJ, Gellett JS, Davidson EP et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001; 50: 1927-1937
195. Dam PS van, Asbeck BS van, Oirschot JF Van et al. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state. Eur J Clin Invest 2001; 31: 417-424
196. Lynch MA. Lipoic acid confers protection against oxidative injury in non-neuronal and neuronal tissue. Nutr Neurosci 2001; 4: 419-438
197. Garrett-Laster M, Russell RM, Jacques PF. Impairment of taste and olfaction in patients with cirrhosis: the role of vitamin A. Hum Nutr Clin Nutr 1984; 38: 203-214
198. Schiffmann S. Drugs influencing taste and smell perception. In: Getchell TV, Doty RL, Bartoshuk LM et al. (eds): Smell and Taste in Health and Disease. New York: Raven Press, 1991: 845-850
199. Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994; 11: 318-377
200. Ackerman BH, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy 1997; 17: 482-496
201. Michael W. Anosmia treated with acupuncture. Acupunct Med 2003; 21: 153-154
202. Tanaka O, Mukaino Y. The effect of auricular acupuncture on olfactory acuity. Am J Chin Med 1999; 27: 19-24
203. Ponsen MM, Stoffers D, Booij J et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004; 56: 173-181
204. Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 1998; 55: 84-90
205. Doty RL, Reyes P, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987; 18: 597-600
206. Bacon AW, Bondi MW, Salmon DP, Murphy C. Very early changes in olfactory functioning due to Alzheimer's disease. Ann N Y Acad Sci 1998; 855: 723-731
207. Liberini P, Parola S, Spano PF, Antonini L. Olfaction in Parkinson's disease: methods of assessment and clinical relevance. J Neurol 2000; 247: 88-96
208. Liberini P, Parola S, Spano PF, Antonini L. Olfactory dysfunction in dementia associated with Lewy bodies. Parkinsonism Relat Disord 1999; 5: 30
209. McShane RH, Nagy Z, Esiri MM et al. Anosmia in demented is associated with Lewy bodies rather than Alzheimer's pathology. J Neurol Neurosurg Psychiatry 2001; 70: 739-743
210. Nordin S, Paulsen JS, Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1995; 1: 281-290
211. Doty RL, Li C, Mannon LJ, Yousem DM. Olfactory dysfunction in multiple sclerosis: relation to longitudinal changes in plaque numbers in central olfactory structures. Neurology 1999; 53: 880-882
212. Zorzon M, Ukmar M, Zanier F et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Mult Scler 2000; 6: 386-390
213. Blomqvist EH, Lundblad L, Bergstedt H, Stjarne P. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol 2003; 123: 862-868
214. Heilmann S, Hüttenbrink KB, Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol 2004; 18: 29-33
215. Benninger MS, Hadley JA, Osguthorpe JD et al. Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 2004; 130: 5-24
216. Hummel T, Jahnke U, Sommer U et al. Olfactory function in patients with idiopathic Parkinson's disease: Effects of deep brain stimulation in the subthalamic nucleus. J Neural Transm, 2004 Epub
217. Knecht M, Hummel T. Recording of the human electro-olfactogram. Physiol Behav 2004; 83: 13-19
218. Graves AB, Bowen JD, Rajaram L et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999; 53: 1480-1487
219. Elian M. Olfactory impairment in motor neuron disease: a pilot study. J Neurol Neurosurg Psychiatry 1991; 54: 927-928
220. Sajjadian A, Doty RL, Gutnick D et al. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration 1994; 3: 153-157